Key result
KAMMA registry launches to track risk factors and cardiovascular outcomes in ~3,600 multifocal atherosclerosis patients.
Why the study?
Multifocal atherosclerosis is a major medical issue linked to high ischemic risk, yet an international registry unifying diverse populations with manifested and subclinical disease across Eurasian countries was lacking.
Answers are grounded in this paper and cite their sources.
The KAMMA registry is being developed to collect real-world data on the frequency, clinical course, and outcomes of patients with multifocal atherosclerosis in Russia and Eurasian countries.
Highlights Developing international registry that would unify different patient populations not represented in other registries and studies, and include patients with both manifested and subclinical atherosclerosis, is crucial for cardiovascular field. The collected data can be used in national guidelines, teaching and learning guides, and in clinical practice. Abstract Multifocal atherosclerosis (MFA) is one of the key issues in modern medicine. Several vascular beds are involved in the pathological process in every fifth patient with detected atherosclerosis. Moreover, patients with MFA have high risk of ischemic events, lower quality of life, shorter life expectancy and disability. “The Eurasian Association of Internal medicine” proposed to create a registry on real clinical practice in order to collect data on the frequency, detection methods, clinical course, risk factors and outcomes of patients with MFA in specialized centers in Russia and Commonwealth of Independent States (Republic of Kazakhstan, Republic of Uzbekistan, Republic of Belarus).
No takes yet. Share an insight, caveat, or question.
Батлук et al. (2023) conducted an editorial in Multifocal Atherosclerosis (n=3,600). Multifocal atherosclerosis was evaluated on Occurrence of a cardiovascular event (stroke, acute coronary syndrome, amputation, hospitalization, or number of ambulance calls). The KAMMA international registry aims to collect real-world clinical data on the clinical course, risk factors, and outcomes of 3,600 patients with multifocal atherosclerosis in Russia and Eurasian countries.
Synapse has enriched 10 related papers. Consider them for comparative context: